Blanket use of intranasal mupirocin for outbreak control and long-term prophylaxis of endemic methicillin-resistant Staphylococcus aureus in an open ward
- 30 April 1996
- journal article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 32 (4) , 257-266
- https://doi.org/10.1016/s0195-6701(96)90036-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experienceJournal of Hospital Infection, 1994
- Ten years' experience with methicillin-resistant Staphylococcus aureus in a large Australian hospitalJournal of Hospital Infection, 1992
- Minimal dose requirements for nasal mupirocin and its role in the control of epidemic MRSAJournal of Hospital Infection, 1991
- Efficacy of mupirocin nasal ointment in eradicating Staphylococcus aureus nasal carriage in chronic haemodialysis patientsJournal of Hospital Infection, 1991
- Should We Vigorously Try to Contain and Control Methicillin-Resistant Staphylococcus aureus?Infection Control & Hospital Epidemiology, 1991
- The carrier state: methicillin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1986
- Elimination of nasal carriage of Staphylococcus aureus with mupirocin (‘pseudomonic acid’)—a controlled trialJournal of Antimicrobial Chemotherapy, 1986
- Hospital outbreak of multiresistantStaphylococccus aureusin Victoria, 1979‐1984The Medical Journal of Australia, 1985
- Epidemie of hospital‐acquired infection due to methicillin‐resistantStaphylococcus aureusin major Victorian hospitalsThe Medical Journal of Australia, 1982
- "Celbenin" - resistant StaphylococciBMJ, 1961